Avoro Capital Advisors as of March 31, 2020
Portfolio Holdings for Avoro Capital Advisors
Avoro Capital Advisors holds 41 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 11.0 | $330M | 25M | 13.48 | |
| Mirati Therapeutics | 10.5 | $316M | 4.1M | 76.87 | |
| Iovance Biotherapeutics (IOVA) | 10.2 | $307M | 10M | 29.93 | |
| Ascendis Pharma A S (ASND) | 6.7 | $201M | 1.8M | 112.61 | |
| BioMarin Pharmaceutical (BMRN) | 5.4 | $163M | 1.9M | 84.50 | |
| Sarepta Therapeutics (SRPT) | 5.2 | $155M | 1.6M | 97.82 | |
| Horizon Therapeutics | 4.5 | $136M | 4.6M | 29.62 | |
| Karyopharm Therapeutics (KPTI) | 4.5 | $135M | 7.0M | 19.21 | |
| Argenx Se (ARGX) | 4.1 | $123M | 937k | 131.73 | |
| Constellation Pharmceticls I | 3.8 | $115M | 3.7M | 31.43 | |
| Amicus Therapeutics (FOLD) | 3.4 | $101M | 11M | 9.24 | |
| Deciphera Pharmaceuticals (DCPH) | 2.7 | $82M | 2.0M | 41.17 | |
| Uniqure Nv (QURE) | 2.6 | $78M | 1.7M | 47.45 | |
| Acceleron Pharma | 2.6 | $77M | 860k | 89.87 | |
| Adverum Biotechnologies | 2.3 | $70M | 7.2M | 9.77 | |
| Zogenix | 2.3 | $69M | 2.8M | 24.73 | |
| Myokardia | 2.2 | $67M | 1.4M | 46.88 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $54M | 1.2M | 44.61 | |
| Relmada Therapeutics (RLMD) | 1.3 | $39M | 1.2M | 34.11 | |
| Athenex | 1.3 | $38M | 4.9M | 7.74 | |
| Flamel Technologies Sa (AVDL) | 1.2 | $35M | 4.4M | 7.94 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $31M | 2.8M | 11.34 | |
| Tricida | 1.0 | $30M | 1.4M | 22.00 | |
| Sage Therapeutics (SAGE) | 1.0 | $29M | 1.0M | 28.72 | |
| Cue Biopharma (CUE) | 0.9 | $27M | 1.9M | 14.19 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $25M | 1.7M | 14.51 | |
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $23M | 349k | 66.76 | |
| Allogene Therapeutics (ALLO) | 0.7 | $22M | 1.1M | 19.44 | |
| Trillium Therapeutics, Inc. Cmn | 0.7 | $20M | 5.0M | 4.04 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $13M | 522k | 24.95 | |
| Marinus Pharmaceuticals | 0.4 | $13M | 6.2M | 2.03 | |
| Amarin Corporation (AMRN) | 0.4 | $12M | 3.0M | 4.00 | |
| BioDelivery Sciences International | 0.4 | $11M | 3.0M | 3.79 | |
| Revolution Medicines (RVMD) | 0.3 | $9.9M | 450k | 21.91 | |
| Cymabay Therapeutics | 0.3 | $8.1M | 5.5M | 1.48 | |
| Tg Therapeutics (TGTX) | 0.3 | $7.9M | 800k | 9.84 | |
| Agenus (AGEN) | 0.2 | $6.7M | 2.8M | 2.45 | |
| Fennec Pharmaceuticals (FENC) | 0.2 | $6.6M | 1.1M | 5.94 | |
| ImmunoGen | 0.2 | $6.5M | 1.9M | 3.41 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $6.1M | 145k | 42.25 | |
| Alimera Sciences (ALIM) | 0.1 | $1.6M | 416k | 3.84 |
